Leukotrienes play protective roles early during experimental VSV encephalitis

Area of Science:

• Neuroimmunology
• Virology
• Inflammation Research

Background:

• Leukotrienes (LT) are potent lipid mediators of inflammation, primarily studied in airway diseases.
• The role of LT in viral infections within the central nervous system (CNS) remains largely unexplored.
• 5-Lipoxygenase (5-LO) is the key enzyme responsible for LT synthesis.

Purpose of the Study:

• To investigate the role of LT in the pathogenesis of acute vesicular stomatitis virus (VSV) encephalitis.
• To determine the impact of 5-LO inhibition on immune responses and viral control in the CNS.

Main Methods:

• Utilized Zileuton, a 5-LO enzyme antagonist, to inhibit LT production in mice.
• Employed 5-LO genetic knockout mice to study the absence of LT synthesis.
• Assessed neutrophil infiltration, nitric oxide synthase-1 (NOS-1) expression, viral titers, and blood-brain barrier (BBB) integrity.

Main Results:

• Inhibition or genetic deletion of 5-LO led to impaired neutrophil infiltration into the CNS early in VSV infection.
• Fewer neurons expressed NOS-1 in the absence of 5-LO activity.
• Higher viral titers were observed one day post-infection with 5-LO inhibition.
• Increased disruption of the blood-brain barrier (BBB) was noted when 5-LO was inhibited.

Conclusions:

• LT are significant innate immune mediators during VSV pathogenesis in the CNS.
• LT are beneficial to the host, aiding in the early control of viral replication within the CNS.
• Targeting LT pathways may offer therapeutic strategies for viral encephalitis.